Full text is available at the source.
Abstract
Healthcare cost trends were compared among older adults with obesity or overweight treated with tirzepatide versus no treatment.
- Older adults with obesity or overweight may experience different healthcare cost trends depending on treatment status.
- The analysis focuses on the financial implications of using tirzepatide in this demographic.
- Comparative results could highlight potential economic benefits or drawbacks of the treatment.
Simplified